Last update 04 Oct 2024

BAY-1238097

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
BET inhibitor, BAY 1238097
Target
Mechanism
BET inhibitors(Bromodomain and extra terminal domain protein inhibitors)
Therapeutic Areas
Active Indication-
Inactive Indication
Originator Organization
Active Organization-
Inactive Organization
Drug Highest PhaseDiscontinuedPhase 1
First Approval Date-
Regulation-

Structure

Molecular FormulaC25H33N5O3
InChIKeyCJIPEACKIJJYED-KRWDZBQOSA-N
CAS Registry1564268-08-1

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
NeoplasmsPhase 1
US
01 Mar 2015
NeoplasmsPhase 1
FI
01 Mar 2015
NeoplasmsPhase 1
FR
01 Mar 2015
NeoplasmsPhase 1
DE
01 Mar 2015
NeoplasmsPhase 1
CH
01 Mar 2015
NeoplasmsPhase 1
GB
01 Mar 2015
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
8
vlfjebpgmj(xpfkcnbvuz) = 80 mg/week had dose-limiting toxicities (DLTs) (grade 3 vomiting, grade 3 headache and grade 2/3 back pain) vqaylpoljj (peyjctsxio )
Negative
01 Mar 2019
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free